The Role of Botulinum Toxin A in Augmentation of the Effect of Recession and/or Resection Surgery
Presented at the 29th Meeting of ESA and partially appeared in the ‘Transactions’ of the meeting.
Received 27 January 2005; accepted 22 November 2005.
Purpose: The aim of this study is to assess the effectiveness of intraoperative botulinum toxin A (BTA) injection as an adjunct to the surgical treatment of large-angle esotropia or exotropia. Methods: Ten patients were included in the study. Mean age of the patients was 27 ± 20 years. Of these 10 patients, 7 were esotropic and 3 exotropic. The average preoperative esodeviation was 73.6 ± 16.5 prism diopters and exodeviation was 76.7 ± 5.8 PD. Five units of BTA were injected intraoperatively into one of the recessed horizontal rectus muscles in all of the patients. Results: The average follow-up was 14 ± 10 months (range, 8 to 40 months). The average final deviation in the esotropia group was 13 ± 9.6 PD of esotropia. The average final deviation in the exotropia group was 4.7 ± 5 PD of exotropia. The final deviation of the 70% patients was within 10 PD of esotropia or exotropia. Conclusion: The results of this study suggest that the combination of BTA injection with recession may increase the expected correction of a conventional horizontal rectus muscle surgery.
Department of Ophthalmology, Adnan Menderes University, Aydın, Turkey.
Reprint requests: Dr. Seyhan Bahar Özkan, Department of Ophthalmology, Adnan Menderes University Medical School, 09010, Aydın, Turkey.
This study was performed at Adnan Menderes University Medical School Department of Ophthalmology in Aydın, Turkey.